“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...

Seeing the sufferings of my countrymen who cannot afford proper healthcare, it has been my objective to see how I can help create a more equitable health system,' says Dr. Edwin Mercado ...

Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for ...

Learn how to master AI in 2025 with this comprehensive roadmap. Build skills, explore tools, and stay ahead in the evolving ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

WARREN, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy ...

Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.08. Operator: Good morning, ladies and gentlemen, and welcome to ...

Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ETCompany ParticipantsWill McDowell - Vice President ...

The new campaign launched with an open letter from D-Wave CEO Dr. Alan Baratz published in The Wall Street Journal about the status of quantum computing's commercial viability. Dr. Baratz's letter ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days ...

Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...